Wound Care (Pharmacies) - Northern Europe

  • Northern Europe
  • Revenue in the Wound Care market is projected to reach US$49.18m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.48%, resulting in a market volume of US$50.37m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$1,042.00m in 2024).
  • In relation to total population figures, per person revenues of US$1.45 are generated in 2024.

Key regions: China, South Korea, Japan, Canada, India

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Wound Care (Pharmacies) market in Northern Europe is experiencing steady growth and development, driven by customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. Customer preferences in the Wound Care (Pharmacies) market in Northern Europe are shifting towards more advanced and innovative wound care products. Customers are increasingly seeking products that promote faster healing, reduce pain, and minimize scarring. This preference for advanced wound care products is driven by a growing awareness of the importance of proper wound care and the desire for optimal outcomes. Additionally, customers in Northern Europe value products that are easy to use and provide convenience in their daily lives. Trends in the market indicate a growing demand for wound care products in Northern Europe. This can be attributed to several factors. Firstly, the aging population in the region is driving the need for wound care products, as older individuals are more prone to chronic wounds and require specialized care. Secondly, the increasing prevalence of chronic diseases, such as diabetes and obesity, is contributing to the demand for wound care products, as these conditions often lead to slow-healing wounds. Lastly, the growing emphasis on preventive healthcare and early intervention is driving the demand for wound care products, as individuals are taking proactive measures to prevent and treat wounds before they escalate. Local special circumstances in Northern Europe also play a role in the development of the Wound Care (Pharmacies) market. The region has a well-established healthcare system that provides access to high-quality healthcare services, including wound care. This enables individuals to seek timely and appropriate treatment for their wounds, contributing to the overall growth of the market. Additionally, the presence of a large number of pharmacies in Northern Europe ensures easy availability of wound care products to customers, further fueling market growth. Underlying macroeconomic factors also contribute to the development of the Wound Care (Pharmacies) market in Northern Europe. The region has a stable economy and high disposable income levels, allowing individuals to afford and invest in quality wound care products. Furthermore, the presence of a robust healthcare infrastructure and favorable reimbursement policies for wound care products and services incentivizes customers to seek professional wound care solutions. In conclusion, the Wound Care (Pharmacies) market in Northern Europe is developing due to customer preferences for advanced wound care products, market trends such as the aging population and the prevalence of chronic diseases, local special circumstances including access to healthcare services and the presence of pharmacies, and underlying macroeconomic factors such as a stable economy and favorable reimbursement policies. These factors collectively contribute to the growth and development of the market in the region.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)